NCT04885231

Brief Summary

Research question: Does an opioid limiting pain management counseling and education program result in decreased opioid consumption and improved pain control compared to traditional pain management programs after anterior cruciate ligament reconstruction (ACLR) surgery? At many institutions, the current standard of care is to instruct patients to take opioid pain medicine as needed when in severe pain to "stay ahead of the pain." This study is investigating whether modifying the instructions to take opioid pain medications only if in "unbearable pain" will have an effect on 1) reducing opioid consumption and 2) improving pain levels. Adults who are undergoing an ACLR surgery will be invited to participate in the study and be randomly assigned to one of the two pain management programs. All patients will receive a comprehensive multi-modality pain management treatments and medications. Patients in both groups will receive the same type and amount of all postoperative medications. The only difference will be in the instructions about when to take the opioid medications. The patients will then be sent an electronic survey twice per day for 2 weeks about their pain levels and number of opioid pills taken.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
121

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 2, 2021

Completed
10 days until next milestone

Study Start

First participant enrolled

May 12, 2021

Completed
1 day until next milestone

First Posted

Study publicly available on registry

May 13, 2021

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2024

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 29, 2025

Completed
Last Updated

May 2, 2025

Status Verified

April 1, 2025

Enrollment Period

3.3 years

First QC Date

May 2, 2021

Last Update Submit

April 29, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Postoperative opioid consumption

    The total morphine equivalents (TMEs) consumed by the patient after surgery

    3 months

Secondary Outcomes (9)

  • Numeric Pain Scale

    Two weeks

  • Patient Reported Outcomes - Satisfaction with social roles & activities

    2 weeks, 6 weeks, 3 months

  • Patient Reported Outcomes - Physical Function

    2 weeks, 6 weeks, 3 months

  • Patient Reported Outcomes - Pain

    2 weeks, 6 weeks, 3 months

  • Patient Reported Outcomes - Fatigue

    2 weeks, 6 weeks, 3 months

  • +4 more secondary outcomes

Study Arms (2)

Opioid-Limiting Perioperative Pain Management Education and Counseling

EXPERIMENTAL

Patients will be instructed to take oxycodone only as a last resort if the pain becomes unbearable. "The goal should be to take as little oxycodone as possible."

Behavioral: Perioperative Pain Management Education and Counseling

Traditional Perioperative Pain Management Education and Counseling

ACTIVE COMPARATOR

Patients will be instructed to take opioids as needed for severe pain to manage and "stay ahead" of the postoperative pain

Behavioral: Perioperative Pain Management Education and Counseling

Interventions

All patients will receive both verbal postoperative pain management education and counseling as well as a written handout. Multi-modality non-opioid methods of pain control will be thoroughly discussed.

Opioid-Limiting Perioperative Pain Management Education and CounselingTraditional Perioperative Pain Management Education and Counseling

Eligibility Criteria

Age14 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Men and women aged 14 years and older
  • All patients scheduled to undergo an ACLR with or without concomitant procedures such as arthroscopic cartilage procedures, meniscus repair or meniscectomy, and/or lateral extraarticular tenodesis (anterolateral ligament reconstruction)
  • Willing to participate in a perioperative pain management education and counseling program
  • Willing to track pain levels and opioid consumption through surveys administered via text
  • Willing to receive a perioperative regional nerve block
  • Language skills and cognitive ability required to participate in the study
  • Provision of informed consent

You may not qualify if:

  • Revision ACLR
  • Concomitant open cartilage procedures or additional knee ligament repair or reconstruction
  • Concomitant injury that would also influence pain management
  • History of heroin use or opioid abuse requiring treatment
  • If any previous ipsilateral knee surgery except for knee arthroscopy
  • Preoperative Kellgren-Lawrence grade 3 and 4 on weightbearing radiographs
  • An allergy to any of the study medications
  • Previously enrolled in the CARE trial
  • Anticipated problems with the patient returning for follow-up or accurate completion of survey
  • If patient cannot reliably receive texts and use internet to complete surveys

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Maryland Rehabilitation and Orthopaedic Institute

Baltimore, Maryland, 21207, United States

Location

Related Publications (19)

  • Borovkov SA, Shevchuk AG. [Rheologic properties of blood in chronic ischemia of the lower extremities]. Khirurgiia (Mosk). 1982 Jul;(7):44-7. No abstract available. Russian.

    PMID: 7120832BACKGROUND
  • Aso K, Izumi M, Sugimura N, Okanoue Y, Kamimoto Y, Yokoyama M, Ikeuchi M. Additional benefit of local infiltration of analgesia to femoral nerve block in total knee arthroplasty: double-blind randomized control study. Knee Surg Sports Traumatol Arthrosc. 2019 Jul;27(7):2368-2374. doi: 10.1007/s00167-018-5322-7. Epub 2018 Dec 8.

    PMID: 30536047BACKGROUND
  • Dysart SH, Barrington JW, Del Gaizo DJ, Sodhi N, Mont MA. Local Infiltration Analgesia With Liposomal Bupivacaine Improves Early Outcomes After Total Knee Arthroplasty: 24-Hour Data From the PILLAR Study. J Arthroplasty. 2019 May;34(5):882-886.e1. doi: 10.1016/j.arth.2018.12.026. Epub 2018 Dec 25.

    PMID: 30799269BACKGROUND
  • Hyland SJ, Deliberato DG, Fada RA, Romanelli MJ, Collins CL, Wasielewski RC. Liposomal Bupivacaine Versus Standard Periarticular Injection in Total Knee Arthroplasty With Regional Anesthesia: A Prospective Randomized Controlled Trial. J Arthroplasty. 2019 Mar;34(3):488-494. doi: 10.1016/j.arth.2018.11.026. Epub 2018 Nov 23.

    PMID: 30554925BACKGROUND
  • Kim N, Matzon JL, Abboudi J, Jones C, Kirkpatrick W, Leinberry CF, Liss FE, Lutsky KF, Wang ML, Maltenfort M, Ilyas AM. A Prospective Evaluation of Opioid Utilization After Upper-Extremity Surgical Procedures: Identifying Consumption Patterns and Determining Prescribing Guidelines. J Bone Joint Surg Am. 2016 Oct 19;98(20):e89. doi: 10.2106/JBJS.15.00614.

    PMID: 27869630BACKGROUND
  • Kuang MJ, Du Y, Ma JX, He W, Fu L, Ma XL. The Efficacy of Liposomal Bupivacaine Using Periarticular Injection in Total Knee Arthroplasty: A Systematic Review and Meta-Analysis. J Arthroplasty. 2017 Apr;32(4):1395-1402. doi: 10.1016/j.arth.2016.12.025. Epub 2016 Dec 23.

    PMID: 28082044BACKGROUND
  • Kumar K, Gulotta LV, Dines JS, Allen AA, Cheng J, Fields KG, YaDeau JT, Wu CL. Unused Opioid Pills After Outpatient Shoulder Surgeries Given Current Perioperative Prescribing Habits. Am J Sports Med. 2017 Mar;45(3):636-641. doi: 10.1177/0363546517693665. Epub 2017 Feb 9.

    PMID: 28182507BACKGROUND
  • Kunze KN, Polce EM, Lilly DT, Garcia FL, Cohn MR, Nho SJ, Chahla J. Adjunct Analgesia Reduces Pain and Opioid Consumption After Hip Arthroscopy: A Systematic Review of Randomized Controlled Trials. Am J Sports Med. 2020 Dec;48(14):3638-3651. doi: 10.1177/0363546520905884. Epub 2020 Mar 2.

    PMID: 32119562BACKGROUND
  • McLaughlin DC, Cheah JW, Aleshi P, Zhang AL, Ma CB, Feeley BT. Multimodal analgesia decreases opioid consumption after shoulder arthroplasty: a prospective cohort study. J Shoulder Elbow Surg. 2018 Apr;27(4):686-691. doi: 10.1016/j.jse.2017.11.015. Epub 2018 Jan 3.

    PMID: 29305103BACKGROUND
  • Namdari S, Nicholson T, Abboud J, Lazarus M, Steinberg D, Williams G. Interscalene Block with and without Intraoperative Local Infiltration with Liposomal Bupivacaine in Shoulder Arthroplasty: A Randomized Controlled Trial. J Bone Joint Surg Am. 2018 Aug 15;100(16):1373-1378. doi: 10.2106/JBJS.17.01416.

    PMID: 30106818BACKGROUND
  • Pitchon DN, Dayan AC, Schwenk ES, Baratta JL, Viscusi ER. Updates on Multimodal Analgesia for Orthopedic Surgery. Anesthesiol Clin. 2018 Sep;36(3):361-373. doi: 10.1016/j.anclin.2018.05.001. Epub 2018 Jul 11.

    PMID: 30092934BACKGROUND
  • Rucinski K, Cook JL. Effects of preoperative opioid education on postoperative opioid use and pain management in orthopaedics: A systematic review. J Orthop. 2020 Jan 21;20:154-159. doi: 10.1016/j.jor.2020.01.020. eCollection 2020 Jul-Aug.

    PMID: 32025140BACKGROUND
  • Schoenfeld AJ, Jiang W, Chaudhary MA, Scully RE, Koehlmoos T, Haider AH. Sustained Prescription Opioid Use Among Previously Opioid-Naive Patients Insured Through TRICARE (2006-2014). JAMA Surg. 2017 Dec 1;152(12):1175-1176. doi: 10.1001/jamasurg.2017.2628.

    PMID: 28813584BACKGROUND
  • Sethi PM, Brameier DT, Mandava NK, Miller SR. Liposomal bupivacaine reduces opiate consumption after rotator cuff repair in a randomized controlled trial. J Shoulder Elbow Surg. 2019 May;28(5):819-827. doi: 10.1016/j.jse.2019.01.008. Epub 2019 Mar 28.

    PMID: 30928396BACKGROUND
  • Sun EC, Darnall BD, Baker LC, Mackey S. Incidence of and Risk Factors for Chronic Opioid Use Among Opioid-Naive Patients in the Postoperative Period. JAMA Intern Med. 2016 Sep 1;176(9):1286-93. doi: 10.1001/jamainternmed.2016.3298.

    PMID: 27400458BACKGROUND
  • Syed UAM, Aleem AW, Wowkanech C, Weekes D, Freedman M, Tjoumakaris F, Abboud JA, Austin LS. Neer Award 2018: the effect of preoperative education on opioid consumption in patients undergoing arthroscopic rotator cuff repair: a prospective, randomized clinical trial. J Shoulder Elbow Surg. 2018 Jun;27(6):962-967. doi: 10.1016/j.jse.2018.02.039. Epub 2018 Mar 26.

    PMID: 29599038BACKGROUND
  • Tedesco D, Gori D, Desai KR, Asch S, Carroll IR, Curtin C, McDonald KM, Fantini MP, Hernandez-Boussard T. Drug-Free Interventions to Reduce Pain or Opioid Consumption After Total Knee Arthroplasty: A Systematic Review and Meta-analysis. JAMA Surg. 2017 Oct 18;152(10):e172872. doi: 10.1001/jamasurg.2017.2872. Epub 2017 Oct 18.

    PMID: 28813550BACKGROUND
  • Volkow ND, McLellan TA, Cotto JH, Karithanom M, Weiss SR. Characteristics of opioid prescriptions in 2009. JAMA. 2011 Apr 6;305(13):1299-301. doi: 10.1001/jama.2011.401. No abstract available.

    PMID: 21467282BACKGROUND
  • Xiao K, Yu L, Xiao W, Peng H, Bian Y, Wu Z, Weng X. Pain Management Using Perioperative Administration of Parecoxib for Total Hip Arthroplasty: A Randomized, Double-Blind, Placebo-Controlled Trial. Pain Physician. 2019 Nov;22(6):575-582.

    PMID: 31775404BACKGROUND

MeSH Terms

Conditions

Pain, Postoperative

Interventions

Counseling

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

Mental Health ServicesBehavioral Disciplines and ActivitiesCommunity Health ServicesHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Jonathan D. Packer, MD

    University of Maryland, Baltimore

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Single center randomized control trial consisting of two groups - one control and one experimental.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

May 2, 2021

First Posted

May 13, 2021

Study Start

May 12, 2021

Primary Completion

September 1, 2024

Study Completion

April 29, 2025

Last Updated

May 2, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations